Liqufruta

Product NDC: 75939-9876
11-digit product format: 759399876
Labeler code: 75939
Product ID: 75939-9876_410a54c1-cdb4-465b-83f6-9986185f2ff1
Type: HUMAN OTC DRUG
Nonproprietary name: GUAIFENESIN
Dosage form: SYRUP
Route: ORAL
Labeler: Alston Garrard & Co
Application: part341
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2011-01-01
Marketing end: 0000-00-00
Substance: GUAIFENESIN
Active strength: 50 mg/5mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	75939-9876		I	Inactivated by FDA	2026-10-05
excluded product	product	75939-9876		I	Inactivated by FDA	2026-10-05
excluded package	package	75939-9876	75939-9876-2	I	Inactivated by FDA	2026-10-05
excluded package	package	75939-9876	75939-9876-1	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 88 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	75939-9876-2	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	75939-9876-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	75939-9876-2	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	75939-9876-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	75939-9876-2	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	75939-9876-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	75939-9876-2	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	75939-9876-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	75939-9876-2	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	75939-9876-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	75939-9876-2	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	75939-9876-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	75939-9876-2	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	75939-9876-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	75939-9876-2	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	75939-9876-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	75939-9876-2	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	75939-9876-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	75939-9876-2	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	75939-9876-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	75939-9876-2	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	75939-9876-1	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	75939-9876-2	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	75939-9876-1	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	75939-9876-2	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	75939-9876-1	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	75939-9876-2	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	75939-9876-1	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	75939-9876-2	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	75939-9876-1	`1332a3947898…`	`d4bfe170f9cd…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
48747306-602a-42cc-957b-5b0c69158eee	Product name	1	20180604
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
4fe95224-f543-4dbb-9445-8cca122b48c8	Product name	1	20150609
e8718272-64cb-4436-969b-176c3067c8f4	Product name	1	20150609
106ff02a-57e1-4c4c-a307-fd582ff4e311	Product name	1	20150212
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
75939-9876-2	2019-11-13	C162847	48780-1	97449f38-b92a-f6ea-e053-dbdaa90aa703	Liqufruta Herbal Garlic Cough Syrup Guaifenensin Oral Solution,USP
75939-9876-1	2019-10-29	C162847	48780-1	960f7f55-d568-8e05-e053-dbdaa90a074a	Liqufruta Herbal garlic Cough Syrup Guaifenensin Oral Solution,USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
75939-9876-2	Liqufruta	200 mL in 1 BOTTLE, PLASTIC	SYRUP	200		7

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GUAIFENESIN	ACTIVE INGREDIENT	495W7451VQ	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
GUAIFENESIN	ACTIVE MOIETY	495W7451VQ	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
ACETIC ACID	INACTIVE INGREDIENT	Q40Q9N063P	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
CARAMEL	INACTIVE INGREDIENT	T9D99G2B1R	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
GARLIC OIL	INACTIVE INGREDIENT	4WG8U28833	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
HIGH FRUCTOSE CORN SYRUP	INACTIVE INGREDIENT	XY6UN3QB6S	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
MENTHOL	INACTIVE INGREDIENT	L7T10EIP3A	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7
GUAIFENESIN	ACTIVE INGREDIENT	495W7451VQ	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4
GUAIFENESIN	ACTIVE MOIETY	495W7451VQ	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4
ACETIC ACID	INACTIVE INGREDIENT	Q40Q9N063P	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4
CARAMEL	INACTIVE INGREDIENT	T9D99G2B1R	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4
GARLIC OIL	INACTIVE INGREDIENT	4WG8U28833	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4
HIGH FRUCTOSE CORN SYRUP	INACTIVE INGREDIENT	XY6UN3QB6S	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4
MENTHOL	INACTIVE INGREDIENT	L7T10EIP3A	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
75939-9876	LIQUFRUTA (GUAIFENESIN) SYRUP [ALSTON GARRARD & CO]	7	Legacy NDC, 1 package rows	20120531_ca244516-2177-438a-925f-6d84bd8985ee.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
495W7451VQ	GUAIFENESIN	93-14-1	GUAIFENESIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
636574	guaiFENesin 50 MG in 5 mL Oral Solution	PSN	ca244516-2177-438a-925f-6d84bd8985ee	7
1117402	Liqufruta 50 MG in 5 mL Oral Solution	PSN	ca244516-2177-438a-925f-6d84bd8985ee	7
1117402	guaifenesin 10 MG/ML Oral Solution [Liqufruta]	SBD	ca244516-2177-438a-925f-6d84bd8985ee	7
636574	guaifenesin 10 MG/ML Oral Solution	SCD	ca244516-2177-438a-925f-6d84bd8985ee	7
636574	guaifenesin 50 MG per 5 ML Oral Solution	SY	ca244516-2177-438a-925f-6d84bd8985ee	7
1117402	Liqufruta 10 MG/ML Oral Solution	SY	ca244516-2177-438a-925f-6d84bd8985ee	7
1117402	Liqufruta 50 MG per 5 ML Oral Solution	SY	ca244516-2177-438a-925f-6d84bd8985ee	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
75939-9876-2	75939987602	200 mL in 1 BOTTLE, PLASTIC	200 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Liqufruta Herbal Garlic Cough Syrup Guaifenensin Oral Solution,USP	Alston Garrard & Co \| Pharmaserve (North West) Ltd	2012-05-30	HUMAN OTC DRUG LABEL	7
Liqufruta Herbal garlic Cough Syrup Guaifenensin Oral Solution,USP	Alston Garrard & Co	2011-07-15	HUMAN OTC DRUG LABEL	4